AstraZeneca asthma shot hits goal but diabetes drug lags rival

LONDON (Reuters) - AstraZeneca's experimental injection for severe asthma cut substantially the need for patients to take problematic oral steroid drugs in a late-stage study, boosting hopes for a medicine that is expected to reach the market later this year.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news